[HTML][HTML] Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines

S Le Vu, M Bertrand, MJ Jabagi, J Botton… - Nature …, 2022 - nature.com
Cases of myocarditis and pericarditis have been reported following the receipt of Covid-19
mRNA vaccines. As vaccination campaigns are still to be extended, we aimed to provide a …

Population-based HIV-1 incidence in France, 2003–08: a modelling analysis

S Le Vu, Y Le Strat, F Barin, J Pillonel… - The Lancet infectious …, 2010 - thelancet.com
Background Routine national incidence testing with enzyme immunoassay for recent HIV-1
infections (EIA-RI) has been done in France since January, 2003. From the reported number …

[HTML][HTML] Stroke, myocardial infarction, and pulmonary embolism after bivalent booster

MJ Jabagi, M Bertrand, J Botton, S Le Vu… - … England Journal of …, 2023 - Mass Medical Soc
Stroke, Myocardial Infarction, and Pulmonary Embolism after Bivalent Booster | NEJM Skip to
main content NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare …

[HTML][HTML] Routine HIV screening in France: clinical impact and cost-effectiveness

Y Yazdanpanah, CE Sloan, C Charlois-Ou, S Le Vu… - PloS one, 2010 - journals.plos.org
Background In France, roughly 40,000 HIV-infected persons are unaware of their HIV
infection. Although previous studies have evaluated the cost-effectiveness of routine HIV …

[HTML][HTML] Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance

S Le Vu, G Jones, F Anna, T Rose, JB Richard… - Nature …, 2021 - nature.com
Assessment of the cumulative incidence of SARS-CoV-2 infections is critical for monitoring
the course and extent of the COVID-19 epidemic. Here, we report estimated seroprevalence …

Risk for myocardial infarction, stroke, and pulmonary embolism following COVID-19 vaccines in adults younger than 75 years in France

J Botton, MJ Jabagi, M Bertrand, B Baricault… - Annals of internal …, 2022 - acpjournals.org
Background: The BNT162b2 (Pfizer–BioNTech) vaccine has been shown to be safe with
regard to risk for severe cardiovascular events (such as myocardial infarction [MI] …

[HTML][HTML] Missed opportunities for HIV testing in newly-HIV-diagnosed patients, a cross sectional study

K Champenois, A Cousien, L Cuzin, S Le Vu… - BMC infectious …, 2013 - Springer
Abstract Background In France, 1/3 HIV-infected patients is diagnosed at an advanced stage
of the disease. We describe missed opportunities for earlier HIV testing in newly-HIV …

Modest public health impact of nontargeted human immunodeficiency virus screening in 29 emergency departments

KW d'Almeida, G Kierzek, P de Truchis… - Archives of Internal …, 2012 - jamanetwork.com
Background To lower the number of undiagnosed infections and to improve early detection,
international health agencies have promoted nontargeted human immunodeficiency virus …

[HTML][HTML] Characteristics associated with the residual risk of severe COVID-19 after a complete vaccination schedule: A cohort study of 28 million people in France

L Semenzato, J Botton, J Drouin, B Baricault… - The Lancet Regional …, 2022 - thelancet.com
Background Prior to the availability of vaccines, the risk factors for developing severe forms
of COVID-19 were mostly older age and various comorbidities such as diabetes …

[HTML][HTML] Late diagnosis and entry to care after diagnosis of human immunodeficiency virus infection: a country comparison

HI Hall, J Halverson, DP Wilson, B Suligoi, M Diez… - PloS one, 2013 - journals.plos.org
Background Testing for HIV infection and entry to care are the first steps in the continuum of
care that benefit individual health and may reduce onward transmission of HIV. We …